Alison R. Amenta, Ph.D.

2007

Justin R. Fallon	grad student	2007	Brown
(Biglycan at synapses, the sarcolemma and as a potential therapeutic for Duchenne muscular dystrophy.)

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Amenta AR, Creely HE, Mercado ML, et al. (2012) Biglycan is an extracellular MuSK binding protein important for synapse stability. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 2324-34
Amenta AR, Yilmaz A, Bogdanovich S, et al. (2011) Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proceedings of the National Academy of Sciences of the United States of America. 108: 762-7
Amenta A, McKechnie B, Abedi M, et al. (2007) G.P.6.10 Systemically-administered biglycan upregulates utrophin and counters dystrophic pathology in mdx mice: A novel pharmacological approach for DMD therapy Neuromuscular Disorders. 17: 804
Mercado ML, Amenta AR, Hagiwara H, et al. (2006) Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1724-6